Monthly Archives: May 2014

Pfizer gives up the chase.

Pfizer is saying today that it does not intend to extend a firm offer for AstraZeneca, bringing an end to its attempt to acquire the UK drug maker.  AZ shareholders were split on the latest offer, and a stumble by AZ would … Continue reading

Posted in Pharmaceutical Industry | Tagged , , | Leave a comment

China crackdowns squeeze pharma margins

From Reuters: A crackdown on corruption and pricing in China’s fast-growing pharmaceutical market has squeezed profits and margins, raising a red flag to global Big Pharma that the days of easy growth in the country may be over. Over the … Continue reading

Posted in Pharmaceutical Industry | Tagged , , | Leave a comment

Vinod Khosla says replacing doctors with data crunchers is good medicine

Valley Beat author Mark Sullivan has a short article on some remarks by Vinod Khosla at Stanford University School of Medicine’s Big Data in Biomedicine Conference: Khosla has for a long time believed that machines armed with mountains of data will (and should) make … Continue reading

Posted in Healthcare, Innovation | Tagged , , , | Leave a comment

More thoughts on drug company R&D productivity ranking

[updated]  Some comments I received on the previous post made me realize there was a more fundamental flaw in drug company R&D productivity rankings that should be highlighted. Drug discovery is by and large a high failure rate multistep process … Continue reading

Posted in Fixing Big Pharma Research, Pharmaceutical Industry | Tagged | Leave a comment

Who’s The Best In Drug Research? 22 Companies Ranked Incorrectly

Matt Herper at Forbes has a post on new pharmaceutical research productivity data from Richard Evans, a former Roche executive and Wall Street analyst.  Evans calculates metrics such as (1) Economic Returns to R&D spending, (2) Patents / $1M R&D spend, (3) Average … Continue reading

Posted in Fixing Big Pharma Research, Pharmaceutical Industry | Tagged , , | Leave a comment

Software is still eating the world

Russ Roberts has a new EconTalk podcast interview with Marc Andreessen that is worth a listen: Marc Andreessen, venture capitalist and co-creator of the early web browser Mosaic, talks with EconTalk host Russ Roberts about how success in venture capital is more about … Continue reading

Posted in Data Analysis, Innovation | Tagged , , , | Leave a comment

Apple and Google poised to enter the 3D printing market?

Speculation has been building that Apple and Google might be gearing up to produce consumer 3D printers (along with other tech giants).  Indeed, analysts have been urging Apple to do so. Apple, of course, was primarily responsible for the desktop publishing phenomena, … Continue reading

Posted in 3-D Printing, Innovation | Tagged , , , , | Leave a comment

Most Selective Colleges by State

Each state is marked with the logo of the most selective college located within that state.

Posted in Data Analysis | Tagged , | 3 Comments

MakerBot launches a push-button consumer 3D-printer

MakerBot‘s newest 3-D printer, the Makerbot Replictor Mini, started shipping yesterday.   Employing fast and easy “One Touch” 3D printing, the Mini is a cost-effective solution for small scale prototyping or teaching kids about creating and printing in three dimensions.  Makerbot also sells … Continue reading

Posted in 3-D Printing, Innovation | Tagged , , , | 1 Comment

Pfizer raises its bid for AstraZeneca – one last time?

Over the weekend, Pfizer finally made an official offer for AstraZeneca,  by raising its bid to $119B (15% higher than the last, unofficial, offer), and increasing the cash portion of the deal from 33% to 45%.  AZ had a market cap of … Continue reading

Posted in Pharmaceutical Industry | Tagged , , , | Leave a comment